709 related articles for article (PubMed ID: 19687418)
21. Phenotypic variability among café-au-lait macules in neurofibromatosis type 1.
Boyd KP; Gao L; Feng R; Beasley M; Messiaen L; Korf BR; Theos A
J Am Acad Dermatol; 2010 Sep; 63(3):440-7. PubMed ID: 20605257
[TBL] [Abstract][Full Text] [Related]
22. Eye disorders in neurofibromatosis (NF1).
Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
[TBL] [Abstract][Full Text] [Related]
23. Case report: Gene mutation analysis and skin imaging of isolated café-au-lait macules.
Zhong Z; Yang T; Liu S; Wang S; Zhou S; Du S; Zheng L; Wang X; Wang H; Wang Y; Gao M
Front Genet; 2023; 14():1126555. PubMed ID: 37025448
[No Abstract] [Full Text] [Related]
24. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
[TBL] [Abstract][Full Text] [Related]
25. Mutational spectrum by phenotype: panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café-au-lait macules.
Castellanos E; Rosas I; Negro A; Gel B; Alibés A; Baena N; Pineda M; Pi G; Pintos G; Salvador H; Lázaro C; Blanco I; Vilageliu L; Brems H; Grinberg D; Legius E; Serra E
Clin Genet; 2020 Feb; 97(2):264-275. PubMed ID: 31573083
[TBL] [Abstract][Full Text] [Related]
26. [Neurofibromatosis in children. Our experience].
López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
[TBL] [Abstract][Full Text] [Related]
27. Treatment of cafe au lait macules with lasers. A clinicopathologic correlation.
Grossman MC; Anderson RR; Farinelli W; Flotte TJ; Grevelink JM
Arch Dermatol; 1995 Dec; 131(12):1416-20. PubMed ID: 7492131
[TBL] [Abstract][Full Text] [Related]
28. Café au lait macules and juvénile polyps.
Pacheco TR; Scatena LS; Hoffenberg EJ; Gralla J; Lee LA
Pediatr Dermatol; 2007; 24(3):E17-21. PubMed ID: 17509109
[TBL] [Abstract][Full Text] [Related]
29. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
Friedrich RE; Hartmann M; Mautner VF
Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
[TBL] [Abstract][Full Text] [Related]
30. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
Thiagalingam S; Flaherty M; Billson F; North K
Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
[TBL] [Abstract][Full Text] [Related]
31. [Angiomatous and cerulodermic macules: early cutaneous signs of neurofibromatosis type I].
Vabres P; de Lonlay P; Amiel J; Lyonnet S; Munnich A; de Prost Y
Ann Dermatol Venereol; 1998 Sep; 125(9):593-4. PubMed ID: 9805547
[TBL] [Abstract][Full Text] [Related]
32. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.
Cambiaghi S; Restano L; Caputo R
Pediatr Dermatol; 2004; 21(2):97-101. PubMed ID: 15078345
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis Type 1: Diagnostic Timelines in Children.
García-Martínez FJ; Hernández-Martín A
Actas Dermosifiliogr; 2023 Mar; 114(3):187-193. PubMed ID: 36370836
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
Odebode TO; Afolayan EA; Adigun IA; Daramola OO
Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
[TBL] [Abstract][Full Text] [Related]
35. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
36. Studies on café au lait spots in neurofibromatosis and pigmented macules of nevus spilus.
Takahasi M
Tohoku J Exp Med; 1976 Mar; 118(3):255-73. PubMed ID: 817416
[TBL] [Abstract][Full Text] [Related]
37. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
[TBL] [Abstract][Full Text] [Related]
38. Cerebral arteriopathy in children with neurofibromatosis type 1.
Rea D; Brandsema JF; Armstrong D; Parkin PC; deVeber G; MacGregor D; Logan WJ; Askalan R
Pediatrics; 2009 Sep; 124(3):e476-83. PubMed ID: 19706560
[TBL] [Abstract][Full Text] [Related]
39. Koebner Phenomenon: Café-au-Lait Spots Developing after a Secondary-Degree Burn in a Patient with Neurofibromatosis Type 1.
Feily A; Niaz MJ; Fort M; Morales-Cruz M; Niaz MO; Lange CS; Ramirez-Fort MK
Skinmed; 2022; 20(1):72-74. PubMed ID: 35435830
[TBL] [Abstract][Full Text] [Related]
40. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
Buteică E; Stoicescu I; Burada F; Stănoiu B
Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
